South Africa currently maintains separate surveillance systems for tuberculosis (TB) and human immunodeficiency virus (HIV). There are future plans for integration of these systems; however, the consistency of information across the existing systems has not previously been assessed. O B J E C T I V E : To determine the completeness and concordance of data in the TB and HIV surveillance systems for TB-HIV co-infected patients. D E S I G N : In a retrospective cohort evaluation of the records of TB-HIV co-infected patients in the Eden District of the Western Cape, data were abstracted from paper-based and electronic TB and HIV surveillance sources. Concordance was measured using Fleiss' kappa coefficient. DESPITE PROGRESS in tuberculosis (TB) and human immunodefi ciency virus (HIV) diagnosis and treatment over the last decade, the TB and HIV coepidemics remain a global pandemic, with over 350 000 TB-related deaths among HIV-infected persons in 2010. 1 The two diseases present an enormous public health challenge for high-burden countries, such as South Africa, where 60% of patients diagnosed with TB in 2010 were also infected with HIV. 1
S E T T I N G :
South Africa currently maintains separate surveillance systems for tuberculosis (TB) and human immunodeficiency virus (HIV). There are future plans for integration of these systems; however, the consistency of information across the existing systems has not previously been assessed.
O B J E C T I V E :
To determine the completeness and concordance of data in the TB and HIV surveillance systems for TB-HIV co-infected patients.
D E S I G N :
In a retrospective cohort evaluation of the records of TB-HIV co-infected patients in the Eden District of the Western Cape, data were abstracted from paper-based and electronic TB and HIV surveillance sources. Concordance was measured using Fleiss' kappa coefficient.
R E S U LT S :
Demographic variables had high completeness and concordance across the TB and HIV systems. Completeness and concordance for clinical variables was somewhat lower, particularly for TB variables in the HIV systems and HIV variables in the TB systems.
C O N C L U S I O N :
Varying levels of completeness and concordance of surveillance data for TB-HIV co-infected patients highlight challenges in the current TB and HIV surveillance systems. Future integration of TB and HIV programs in this region will need to support more accurate data collection at all levels. K E Y W O R D S : integration; electronic register; health information systems DESPITE PROGRESS in tuberculosis (TB) and human immunodefi ciency virus (HIV) diagnosis and treatment over the last decade, the TB and HIV coepidemics remain a global pandemic, with over 350 000 TB-related deaths among HIV-infected persons in 2010. 1 The two diseases present an enormous public health challenge for high-burden countries, such as South Africa, where 60% of patients diagnosed with TB in 2010 were also infected with HIV. 1 The integration of TB and HIV services is a necessary and critical step to prevent new infections, more effectively manage existing infections and combat this devastating co-epidemic.
Recently, there have been increasing calls for greater integration of traditionally separate TB and HIV programs. 2, 3 Better collaboration, including integrated patient monitoring systems, is one of the primary objectives of the most recent Global Plan to Stop TB. 4 Recent initiatives by the South Africa National Department of Health (NDoH) aim to facilitate and increase TB and HIV integration, with particular emphasis on the monitoring and evaluation of co-infected patients. 5 However, as in many countries, the TB and HIV surveillance systems in South Africa were developed and implemented as vertical programs and have historically functioned independently to track and monitor the two diseases. Separate funding mechanisms, a lack of integration at the policy-making level, and independent recording and reporting systems are among the factors that have hampered integrated care and surveillance for TB-HIV co-infected patients. [6] [7] [8] [9] [10] To address these challenges, the TB, HIV/ AIDS, Treatment Support and Integrated Therapy (THAT'SIT) program was established in 2005 as a collaborative project between the South Africa Medical Research Council, the Foundation for Professional Development and the NDoH, with the explicit goal of supporting the NDoH in providing a comprehensive range of integrated services for persons with TB and HIV.
As countries move towards greater integration of TB and HIV services, it is necessary to evaluate the existing established systems to determine the optimal framework for patient management, operational 187 planning and resource allocation. In South Africa, previous evaluations of the information systems have identifi ed issues, including duplication of data collection, poor data quality and limited data use at the local level. 11, 12 One study in Cape Town comparing TB treatment and laboratory registers found substantial inaccuracies in the recording of confi rmed TB cases. 13 Another study found that almost 40% of children hospitalized with culture-confi rmed TB were never registered in the national Electronic TB Register (ETR.Net). 14 To our knowledge, no formal evaluations looking specifi cally at the surveillance of TB-HIV co-infected patients in both the TB and HIV systems have been conducted. This evaluation assessed the operation and challenges of the TB and HIV surveillance systems and the completeness and concordance of data across the systems for patients coinfected with TB and HIV.
METHODS
A retrospective cohort evaluation was conducted in the Eden District of the Western Cape Province in September 2011, and included a comprehensive review of paper and electronic records at selected THAT'SIT-supported NDoH clinics and semistructured interviews.
Study setting and population
Three of seven subdistricts in the Eden District were selected for evaluation based on their large catchment areas and relatively high rates of TB-HIV co-infection. All clinical sites in the designated subdistricts providing either TB or HIV care to at least 10 eligible patients were included. THAT'SIT maintains an electronic database that serves as the primary source for integrated TB and HIV patient-level information at THAT'SITsupported clinics. Eligible patients were identifi ed through the THAT'SIT database and were on both antiretroviral therapy (ART) and anti-tuberculosis treatment during January-August 2011.
Data sources
Data were collected from six surveillance systems: a paper-based TB patient fi le (TB Blue Card), a paperbased TB Register, an electronic TB register (ETR. Net), a paper-based ART patient fi le, an electronic ART register (eRegister) and the THAT'SIT database. The TB Blue Card is a standardized clinical fi le that is completed and updated by a clinician at patient visits. The data in the TB Blue Card is transferred by clinic staff to a paper-based TB Register (Figure 1 ). Lastly, a data capturer or the subdistrict HIV/AIDS, STD, TB (HAST) coordinator transfers the data from the paperbased TB register to ETR.Net. HIV surveillance originates with a standardized paper-based ART fi le completed by a clinician at patient visits. Information from the ART fi le is transferred by either a data capturer or the HAST coordinator to the eRegister. For this evaluation, the TB Blue Card, TB Register, and ETR.Net were considered 'TB sources', while the ART fi le and the eRegister were considered 'HIV sources'.
The THAT'SIT database is maintained by data capturers who travel between clinics and collect integrated information for patients receiving TB and HIV care. If information is missing in the TB Blue Card or ART fi le, the THAT'SIT data capturers review pharmacy records, laboratory reports, and follow up with clinical staff in an effort to collect comprehensive patient data.
Data collection
Data abstraction forms were used to collect a total of 26 demographic and clinical variables from the six surveillance systems. Data abstraction was done only from the designated source fi le; pharmacy and laboratory records were not reviewed. The ETR.Net and eRegister were accessed at subdistrict offi ces, and multiple queries were made to locate patient fi les. The THAT'SIT database was accessed using Microsoft Excel (Microsoft, Redwoods, WA, USA). Semistructured interviews were conducted with NDoH and THAT'SIT staff to provide further insight into the operation of the two systems.
Statistics
Descriptive analysis was performed using SAS, version 9.3 (SAS Institute Inc, Cary, NC, USA). Data completeness was calculated for each variable using the total number of recorded responses for that variable divided by the total number of fi les available for each data source. Data concordance, or agreement between different sources, was calculated for key sociodemographic and TB and HIV indicators using Fleiss' κ coeffi cient. 15 Only non-missing responses were used in calculations of concordance.
Ethics
This evaluation underwent ethical review by the South Africa Medical Association Ethics Board, the Provincial Government of the Western Cape and the United States Centers for Disease Control and Prevention. The project was determined to be a public health program evaluation not requiring oversight by a human subjects' institutional review board.
RESULTS
Twelve clinical sites from the three subdistricts of Bitou, Knysna and George were included in the evaluation ( Figure 2 ). All eligible patients at those sites were included, with the exception of a single site where time constraints limited the record review to 37 randomly selected patients among 70 eligible patients. Of the 206 patients identifi ed by the THAT'SIT database, 193 were included in the fi nal evaluation. Twenty-nine patients were missing fi les in at least one data source; 164 (85%) had fi les that could be located in all six systems.
Completeness results
Demographic variables typically had high levels of completeness; date of birth and sex had more than 98% completeness in all six systems (Table 1) . Clinical variables had greater variability in the level and range of completeness. TB site of disease (i.e., pulmonary or extra-pulmonary) was complete in 92-100% of TB sources, 49% of ART fi les, and 100% of THAT'SIT database entries. TB regimen was complete in 98-100% of TB sources, 48% of ART fi les, and 100% of THAT'SIT database entries. TB treatment start date was complete in 100% of TB sources, 87% of ART fi les and 100% of THAT'SIT database entries. These TB-related variables are not collected in the eRegister.
ART treatment start date was complete in 97-100% of HIV sources, 13-66% of TB sources and 99% of THAT'SIT database entries. Initial ART regimen was complete in 96-99% of HIV sources and 100% of THAT'SIT database entries, but is not collected in the TB sources. Receipt of cotrimoxazole preventive therapy (CPT) is collected in all six systems; documentation of CPT ranged from 85-97% in the TB sources to 27-75% in the HIV sources and 100% in the THAT'SIT database.
Concordance results
The concordance for sex was high across all six systems, with a κ of 0.94 (Table 2) . Concordance for TB site of disease was 0.90 across the TB sources and 0.53 across all sources. Concordance for TB regimen was 0.92 across the TB sources and 0.78 across all sources. Among the TB sources, concordance was generally higher between the paper-based TB Blue 
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Card and TB Register than between either of the paper-based sources and ETR.Net. ART regimen, which is not collected in the TB sources, had a concordance of 0.77 between the HIV sources and an overall concordance of 0.68. Concordance for CPT was particularly low, at 0.21 across the TB sources, 0.08 between the ART fi le and the eRegister, and -0.06 overall.
Qualitative results
Semi-structured interviews and direct interaction with the data sources enhanced our understanding of data fl ow in the systems. The surveillance systems depend on data transfer from clinical fi les to electronic registers, but data transfer was not always straightforward. In several cases, the variables and fi elds in the electronic registers did not directly correlate with the variables and fi elds in the paper-based source fi les. For example, the ART fi le asks whether a patient has current TB, with choices of 'Yes' and 'No', and subfi elds asking for the date of anti-tuberculosis treatment initiation and the treatment regimen. Meanwhile, the eRegister asks whether a patient is on anti-tuberculosis treatment at the start of ART, with choices of 'Yes', 'No', and 'Not Sure'. Interview respondents also reported feeling overwhelmed by the number of variables collected for the surveillance systems. Many expressed frustration that they see no local benefi t to their participation in surveillance data collection, do not have access to the data collected in the electronic registers and seldom receive reports back from central levels. 
DISCUSSION
This study found varying levels of completeness and concordance in the current TB and HIV surveillance systems for TB-HIV co-infected patients in South Africa. Demographic variables had consistently high completeness and concordance. Among clinical variables, TB-related variables were typically complete in the TB sources, and HIV-related variables were typically complete in the HIV sources. Conversely, TBrelated variables were often incomplete in the HIV sources, and HIV-related variables were often incomplete in the TB sources. These inconsistencies were confi rmed by the lower concordance of clinical variables. Although concordance of clinical variables was still relatively high, the lower κ levels call attention to the challenges of collecting data refl ecting TB-HIV co-infection under separate TB and HIV surveillance systems. The THAT'SIT database collects all TB and HIV data required for clinical management and program evaluation in a single entry. This streamlined process simplifi es the integration of information required across two service delivery programs. Several factors likely contribute to the low data completeness and concordance seen with select variables in this study. First, despite the advantages and benefi ts of electronic registers, the paper-based clinical fi les remain the foundation of the TB and HIV surveillance systems. 16 Incomplete or inaccurate clinical fi les will translate into incomplete and inaccurate data captured in the electronic registers. Furthermore, in contrast to THAT'SIT, the national program does not have the resources required to review multiple data sources to collect complete information on TB and HIV. Accurate data transfer is also critical, and the apparent drop in concordance between the paperbased TB sources and ETR.Net may indicate errors in the data transfer process. Missing fi les were another signifi cant problem and further limit the data quality and reliability of the surveillance systems. To address these issues, program managers could conduct periodic fi le audits with clinic staff to identify gaps in data recording and reporting and reinforce accurate and complete data collection from patient contact through the data transfer process.
The lack of consistency in data collection also increases the potential for error. For example, when looking at how the ART fi le and the eRegister record current TB information, not only are the fi elds different, with one capturing current TB and the other capturing concurrent anti-tuberculosis treatment, but an additional response option that is offered in the eRegister adds ambiguity to the data. An integrated surveillance system should collect a uniform set of variables in a consistent manner to ensure simple and direct data transfer.
The particularly low completeness and lack of concordance with CPT highlight some of the current obstacles to integrated surveillance. First, there are confl icting protocols and guidelines for the administration of CPT to patients, and program accountability is not clearly defi ned. Second, both the TB Blue Card and the ART fi le have fi elds to indicate whether a patient is receiving CPT, but there is no way of knowing whether the patient is already receiving it. As a result, some patients may not receive CPT at all, whereas others may receive it twice, and still others may be receiving CPT appropriately, but that information is not refl ected in the surveillance systems.
The separate TB and HIV systems make the surveillance of co-infected patients inherently more complicated than surveillance of patients infected with either TB or HIV, but not both. Data refl ecting TB-HIV co-infection are particularly susceptible to error, as patients often receive their TB and HIV care at separate facilities that use different forms without established protocols for communication between the sites. The integrated electronic patient management system in the THAT'SIT database provides a single source for information critical to patient management as well as comprehensive surveillance data with common data elements across multiple diseases. The benefi ts of the integrated THAT'SIT database should be balanced against the extra resources necessary to maintain a parallel data collection system.
A limitation of this study is that completeness and concordance cannot be equated with accuracy or with appropriate clinical care. While high completeness and concordance likely indicate accurate data, low completeness and concordance can only draw attention to data discrepancies. This study was also limited by its focus on the Eden District, and the study population is not necessarily representative of other provinces in South Africa or even other districts in the Western Cape Province. Moreover, all of the clinics in this study are THAT'SIT-supported clinics, which often have additional resources, including patient trackers and dedicated TB and HIV nursing staff. Finally, as eligible patients were identifi ed from the THAT'SIT database, study inclusion was dependent upon its accuracy.
The fi ndings of this evaluation provide additional momentum for the integration of TB and HIV surveillance systems. Our results support the pressing need for even greater integration between surveillance systems, and more accurate data collection and reporting at all levels. National integration will allow for the elimination of parallel data collection systems, both within the NDoH and with partner organizations such as THAT'SIT. However, integrated surveillance will continue to be a challenge in the absence of integrated patient management and clinical care. Smaller initiatives piloting integrated TB and HIV programs have already demonstrated improved clinical outcomes and underscore the benefi ts of integration on a national scale. 17, 18 As South Africa moves away from vertical programs towards more integrated health care delivery across all sectors, the integration of surveillance will be instrumental to monitor the progress of any new initiatives. A minimum data set for national reporting can reduce the reporting burden at the local level; local staff can then be encouraged to monitor and analyze their own data. Well-informed and specifi c steps towards integration are undoubtedly an essential component of the ongoing efforts to combat the TB and HIV co-epidemic. The integration of TB and HIV care and surveillance systems will eliminate duplication, enhance accurate data collection and, ultimately, provide a better refl ection of clinical management and outcomes of TB-HIV co-infected patients in South Africa. 
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